We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · July 20, 2020

Oncological Outcomes in Men With Locally Advanced Prostate Cancer Treated With Neoadjuvant ADT and EBRT Followed by Adjuvant Continuous/Intermittent ADT



Additional Info

Disclosure statements are available on the authors' profiles:

Oncological Outcomes for Patients With Locally Advanced Prostate Cancer Treated With Neoadjuvant Endocrine and External-Beam Radiation Therapy Followed by Adjuvant Continuous/Intermittent Endocrine Therapy in an Open-Label, Randomized, Phase 3 Trial
Cancer 2020 Jun 23;[EPub Ahead of Print], K Ito, M Kobayashi, M Komiyama, S Naito, K Nishimura, J Yonese, K Hashine, S Saito, G Arai, M Shinohara, N Masumori, N Shimizu, T Satoh, A Yamauchi, T Tochigi, Y Takezawa, H Fujimoto, A Yokomizo, KI Kakimoto, I Fukui, K Karasawa, T Tsukamoto, M Nozaki, M Hasumi, H Ishiyama, M Ohtani, M Kuwahara, M Harada, Y Ohashi, T Kotake, T Kakizoe, K Suzuki, H Yamanaka

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Advanced Prostate Cancer Center of Excellence

Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.

Further Reading